Espinós, Jaime http://orcid.org/0000-0001-6284-7184
Aramendía, José Manuel
González-Martín, Antonio
Santisteban, Marta
Sánchez, Luisa
Vizcay, Ángel
Mínguez, José Ángel
Alcázar, Juan Luis
Funding for this research was provided by:
Universidad de Navarra
Article History
Received: 7 March 2024
Accepted: 12 May 2024
First Online: 10 June 2024
Declarations
:
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Comunidad Foral de Navarra approved this study (EO_2022/1, Código: Systemic_Inflamm-Ov-01).
: J. Espinós, JM. Aramendía, L. Sánchez, A. Vizcay, JA. Minguez, and JL. Alcázar, declare they have no financial interests. A. González – Martín received grants/research supports from GSK, Roche, ISCiii, AECC, received honoraria or consultation fees from Alkermes, Amgen, AstraZeneca, Clovis, Genmab, GSK, HederaDx, Immunogen, Kartos, Karyopharm, Illumina, Mersana, MSD, Novartis, Novocure, Oncoinvent, PharmaMar, Roche, SOTIO, SUTRO, Seagen, Takeda, Tubulis, and participated in company sponsored speaker’s bureau in AstraZeneca, Clovis, GSK, Immunogen, Mersana, MSD, Novocure, PharmaMar, Roche, and Takeda. M. Santisteban received grants from Genetech, honoraria or consultation fees from Roche, and Daichii, and travel expenses from Roche, and Lilly.